Projects funded by the NCN

Enzymatic catalysis as a versatile tool for the synthesis of 1,3-dimethylxanthine derivatives with potential anticancer ...

Call: PRELUDIUM 7 , Panel: ST5

Principal investigator: dr Paweł Borowiecki

Politechnika Warszawska, Politechnika Warszawska

Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i...

Call: PRELUDIUM BIS 4 , Panel: NZ7

Principal investigator: prof. Janusz Szemraj

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

PGPB or are they only an environmentally friendly biopreparation? Effect on soil microbiome, growth, yielding and nutrac...

Call: OPUS 23 , Panel: NZ9

Principal investigator: prof. Urszula Gawlik-Dziki

Uniwersytet Przyrodniczy w Lublinie

Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1...

Call: PRELUDIUM 18 , Panel: NZ5

Principal investigator: Aneta Wiśniewska

Uniwersytet Jagielloński, Wydział Chemii

Research of a new small-molecule 1,2,4-triazine derivative (MM-129) - assessment of anti-neoplastic activity and safety ...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Dariusz Pawlak

Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

The second life of salinomycin: Chemo- and regioselective modifications of salinomycin and their influence on the anti-c...

Call: SONATA 12 , Panel: ST5

Principal investigator: dr Michał Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Look at the mechanism of ovarian cancer cells response to adenine nucleosides modified with metallacarborane clusters wi...

Call: OPUS 9 , Panel: NZ3

Principal investigator: dr Katarzyna Bednarska

Instytut Biologii Medycznej PAN